Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE)
Authors:
- Parker KnueppelPKParker Knueppel
- Seo Hyoun BangSBSeo Hyoun Bang
- Camille TroyerCTCamille Troyer
- Alyssa BarrigaABAlyssa Barriga
- Jaekyu ShinJSJaekyu Shin
- Christine L. CadizCCChristine L. Cadiz
- Connie AbdoCAConnie Abdo
- Taylor McCartTMTaylor McCart
- Brittany HuynhBHBrittany Huynh
- Craig StevensCSCraig Stevens
- Crystal ZhouCZCrystal Zhou
- Nuen Tsang YangNYNuen Tsang Yang
- 24 October 2022
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 220, 91-96
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Apixaban Pharmacokinetics at Steady State in Hemodialysis PatientsJournal of the American Society of Nephrology, 2017
- Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) TrialJournal of the American Heart Association, 2015
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2014
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Chronic kidney disease and venous thromboembolism: epidemiology and mechanismsCurrent Opinion in Pulmonary Medicine, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Chronic Kidney Disease Increases Risk for Venous ThromboembolismJournal of the American Society of Nephrology, 2008
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005
- A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous ThromboembolismNew England Journal of Medicine, 1995